TY - JOUR
T1 - Contemporary Treatment of Locally Advanced Oral Cancer
AU - Kim, David
AU - Li, Ryan
N1 - Publisher Copyright:
© 2019, Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2019/4/1
Y1 - 2019/4/1
N2 - At our institution, locally advanced oral cancer is most commonly treated with surgical resection, immediate reconstruction, and adjuvant radiotherapy with or without concurrent systemic therapy depending on final surgical pathologic analysis. There are patients with markedly advanced local or regional disease who unfortunately will have a low probability of cure. We counsel these patients on induction chemotherapy, emphasizing that this is unlikely to result in a smaller volume of surgical resection. In these patients, a good response to induction chemotherapy is more frequently followed by concurrent chemoradiotherapy. We have not been in the practice of commonly recommending definitive chemoradiotherapy for locally advanced oral cancer when upfront surgery is an option. However, as reviewed below, there is a significant rationale for definitive chemoradiotherapy in patients who are surgical candidates, with the hope of good oncologic outcomes, and potential functional organ preservation. The experts who report their experiences in the studies reviewed below provide a strong argument for considering this approach.
AB - At our institution, locally advanced oral cancer is most commonly treated with surgical resection, immediate reconstruction, and adjuvant radiotherapy with or without concurrent systemic therapy depending on final surgical pathologic analysis. There are patients with markedly advanced local or regional disease who unfortunately will have a low probability of cure. We counsel these patients on induction chemotherapy, emphasizing that this is unlikely to result in a smaller volume of surgical resection. In these patients, a good response to induction chemotherapy is more frequently followed by concurrent chemoradiotherapy. We have not been in the practice of commonly recommending definitive chemoradiotherapy for locally advanced oral cancer when upfront surgery is an option. However, as reviewed below, there is a significant rationale for definitive chemoradiotherapy in patients who are surgical candidates, with the hope of good oncologic outcomes, and potential functional organ preservation. The experts who report their experiences in the studies reviewed below provide a strong argument for considering this approach.
KW - Immunotherapy
KW - Neoadjuvant therapy
KW - Oral cavity squamous cell carcinoma
KW - Outcome
KW - Primary chemoradiotherapy
KW - Treatment
UR - http://www.scopus.com/inward/record.url?scp=85062958674&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85062958674&partnerID=8YFLogxK
U2 - 10.1007/s11864-019-0631-8
DO - 10.1007/s11864-019-0631-8
M3 - Review article
C2 - 30874958
AN - SCOPUS:85062958674
SN - 1527-2729
VL - 20
JO - Current Treatment Options in Oncology
JF - Current Treatment Options in Oncology
IS - 4
M1 - 32
ER -